ABSTRACT
3-Hydroxyflavone (3-HF), which binds to the minor groove of DNA, is a strong antioxidant and hence a potent therapeutic and diagnostic agent. A special photo-property, called excited state intramolecular proton transfer (ESIPT), makes the 3-HF derivatives sensitive to the cellular hydrophobic microenvironment. The present study depicts the various changes in the ESIPT of 3-HF due to cationic surfactant-induced compaction of DNA.
Subject(s)
Protons , Surface-Active Agents , DNA , FlavonolsABSTRACT
BACKGROUND: Chest pain is a common presenting symptom in the emergency department (ED). The HEART (history, electroencephalogram [ECG], age, risk factors, and troponin I) score, with addition of troponin at 3 h, helps to determine appropriate risk stratification of the patients. OBJECTIVE: This study evaluated the utility of the HEART pathway as a decision aid designed for risk stratification of patients with acute-onset chest pain for early and safe disposition. METHODS: This was a prospective observational study done in a tertiary care center. Focused history, 12-lead ECG, and baseline troponin I level on arrival and at hour 3 were recorded. Subjects were classified as low risk (HEART score 0-3) or high risk (HEART score ≥ 4). Patients with a HEART score of 0-3 with negative troponin I at 3 h were discharged and were followed up for major adverse cardiac events (MACEs) within 30 days of ED presentation. RESULTS: A total of 250 patients were screened for the study, of which 151 were included for the final analysis. One hundred and two patients (68%) were male and 54% of patients were younger than 45 years. HEART scores of 0 (n = 16), 1 (n = 43), 2 (n = 44), and 3 (n = 48) were observed. There was only 1 MACE (0.7%) in 30 days after ED discharge in the study population. The mean length of ED stay in the low-risk group was 4.5 h. CONCLUSIONS: Low-risk patients, as per the HEART pathway, can be discharged safely from the ED, which reduces ED stay and health care resource use.
Subject(s)
Acute Coronary Syndrome , Electrocardiography , Chest Pain/diagnosis , Chest Pain/etiology , Emergency Service, Hospital , Humans , Male , Risk Assessment , Risk Factors , TroponinABSTRACT
BACKGROUND: Various risk-stratification scores have been developed to identify low-risk febrile neutropenia (FN). The Multinational Association of Supportive Care in Cancer (MASCC) score is a commonly used validated scoring system, although its performance varies due to its subjectivity. Biomarkers like procalcitonin (PCT) are being used in patients with FN to detect bacteremia and additional complications. OBJECTIVE: Our objective was to compare the performance of MASCC score with PCT in predicting adverse outcomes in patients with FN. METHODS: This was a prospective observational study that included chemotherapy-induced FN in hematologic or solid malignancy. The MASCC score, PCT levels, and blood cultures were taken at the first point of contact, and patient treatment was managed according to routine institutional protocol. The primary outcome was mortality at 30 days. RESULTS: A total of 100 patients were recruited, of which 92 had hematologic malignancy and 8 had solid malignancy. Forty-six patients were classified as low risk by MASCC score (≥21). The PCT threshold, 1.42 ng/mL, was taken as a cutoff value, with area under the receiver operating characteristic curve (AUROC) of 0.664 (95% confidence interval [CI] -0.55 to 0.77) for predicting mortality. AUROC for MASCC was 0.586 (95% CI 0.462 to 0.711). CONCLUSIONS: PCT is a useful marker with better prognostic efficacy than MASCC score in patients with FN and can be used as an adjunct to the score in risk-stratifying patients with FN.
Subject(s)
Antineoplastic Agents , Febrile Neutropenia , Neoplasms , Antineoplastic Agents/therapeutic use , Emergency Service, Hospital , Febrile Neutropenia/diagnosis , Humans , Neoplasms/complications , Neoplasms/drug therapy , Predictive Value of Tests , Procalcitonin/therapeutic use , Prognosis , Risk AssessmentABSTRACT
A dopamine-functionalized carbon nanoparticle (CNP)-based platform is designed to reversibly control the optical signal, leading to a multifunctional logic system regulated by pH and light. pH-regulated unique reversible transformation of oxidized and reduced forms of a neurotransmitter, dopamine, conjugated with CNPs plays a decisive role in capturing the final output of the logic function. Inspired by this phenomenon, herein, we report the use of dopamine-docked CNPs to construct different molecular logic gates with an intention to develop the next-generation molecular logic gates. We could successfully construct two basic molecular logic gates, namely, YES and NOT, using one input; two modular logic gates; an IMPLICATION logic gate using two inputs; and finally a combination of OR and AND gates using three inputs. The optical response of the synthesized NP conjugate provides a fluorescence-based "Erase-Read-Write-Read" function. The proposed phenomenon may open a new concept of biochemical logic gates with fluorescence output for neuronal imaging.